XML 52 R39.htm IDEA: XBRL DOCUMENT v3.24.3
Significant Accounting Policies - Disaggregation of Revenue (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Disaggregation of Revenue [Line Items]        
Revenues $ 94,878 $ 89,487 $ 273,701 $ 263,078
Net investment income (loss) 550 277 1,398 885
Total revenues 95,428 89,764 275,099 263,963
Pharmacy        
Disaggregation of Revenue [Line Items]        
Revenues 54,659 56,198 154,036 164,045
Front Store        
Disaggregation of Revenue [Line Items]        
Revenues 5,196 5,371 15,847 16,597
Premiums        
Disaggregation of Revenue [Line Items]        
Revenues 30,925 24,657 91,983 74,117
Other        
Disaggregation of Revenue [Line Items]        
Revenues 4,098 3,261 11,835 8,319
Operating Segments | Health Care Benefits        
Disaggregation of Revenue [Line Items]        
Revenues 32,555 26,089 96,577 78,302
Net investment income (loss) 423 187 1,076 556
Total revenues 32,996 26,296 97,707 78,920
Operating Segments | Health Care Benefits | Pharmacy        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Operating Segments | Health Care Benefits | Front Store        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Operating Segments | Health Care Benefits | Premiums        
Disaggregation of Revenue [Line Items]        
Revenues 30,914 24,645 91,947 74,079
Operating Segments | Health Care Benefits | Other        
Disaggregation of Revenue [Line Items]        
Revenues 1,659 1,464 4,684 4,285
Operating Segments | Health Services        
Disaggregation of Revenue [Line Items]        
Revenues 40,794 44,064 115,954 127,907
Net investment income (loss) (1) 0 (3) 0
Total revenues 44,129 46,891 126,585 137,697
Operating Segments | Health Services | Pharmacy network        
Disaggregation of Revenue [Line Items]        
Total revenues 24,136 27,981 66,448 83,050
Operating Segments | Health Services | Mail & specialty        
Disaggregation of Revenue [Line Items]        
Total revenues 17,214 17,004 52,127 50,378
Operating Segments | Health Services | Other        
Disaggregation of Revenue [Line Items]        
Total revenues 2,780 1,906 8,013 4,269
Operating Segments | Health Services | Pharmacy        
Disaggregation of Revenue [Line Items]        
Revenues 41,350 44,985 118,575 133,428
Operating Segments | Health Services | Front Store        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Operating Segments | Health Services | Premiums        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Operating Segments | Health Services | Other        
Disaggregation of Revenue [Line Items]        
Revenues 2,780 1,906 8,013 4,269
Operating Segments | Pharmacy & Consumer Wellness        
Disaggregation of Revenue [Line Items]        
Revenues 21,515 19,321 61,127 56,826
Net investment income (loss) 0 (2) 0 (4)
Total revenues 32,423 28,872 90,986 85,578
Operating Segments | Pharmacy & Consumer Wellness | Pharmacy        
Disaggregation of Revenue [Line Items]        
Revenues 26,666 22,977 73,463 67,371
Operating Segments | Pharmacy & Consumer Wellness | Front Store        
Disaggregation of Revenue [Line Items]        
Revenues 5,196 5,371 15,847 16,597
Operating Segments | Pharmacy & Consumer Wellness | Premiums        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Operating Segments | Pharmacy & Consumer Wellness | Other        
Disaggregation of Revenue [Line Items]        
Revenues 561 526 1,676 1,614
Corporate/ Other | Corporate/ Other        
Disaggregation of Revenue [Line Items]        
Revenues 14 13 43 43
Net investment income (loss) 128 92 325 333
Total revenues 142 105 368 376
Corporate/ Other | Corporate/ Other | Pharmacy        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Corporate/ Other | Corporate/ Other | Front Store        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Corporate/ Other | Corporate/ Other | Premiums        
Disaggregation of Revenue [Line Items]        
Revenues 11 12 36 38
Corporate/ Other | Corporate/ Other | Other        
Disaggregation of Revenue [Line Items]        
Revenues 3 1 7 5
Intersegment Eliminations        
Disaggregation of Revenue [Line Items]        
Net investment income (loss) 0 0 0 0
Total revenues (14,262) (12,400) (40,547) (38,608)
Intersegment Eliminations | Pharmacy        
Disaggregation of Revenue [Line Items]        
Revenues (13,357) (11,764) (38,002) (36,754)
Intersegment Eliminations | Front Store        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Intersegment Eliminations | Premiums        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Intersegment Eliminations | Other        
Disaggregation of Revenue [Line Items]        
Revenues $ (905) $ (636) $ (2,545) $ (1,854)